APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposome Drug Delivery

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

Selected research

Industry Growth & Trends

Global Liposome Drug Delivery Industry Growth and Trends Forecast to 2032

8 January 2026109 pages

Choose your research edition.

Industry ResearchLiposome Drug Delivery Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposome Drug Delivery Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Liposome Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposome Drug Delivery Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposome Drug Delivery Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Liposome Drug Delivery market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Liposome Drug Delivery market size, estimates, and forecasts are presented in terms of sales volume (K Vial) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Liposome Drug Delivery market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Liposome Drug Delivery.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Liposome Drug Delivery market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Liposome Drug Delivery Market by Company

Gilead Sciences

Pacira

Sun Pharmaceutical

Johnson & Johnson

Luye Pharma

Sigma-Tau

Ipsen (Onivyde)

CSPC

Teva Pharmaceutical

Novartis

Fudan-Zhangjiang

Liposome Drug Delivery Segment by Type

Liposomal Doxorubicin

Liposomal Amphoteracin B

Liposomal Paclitaxel

Others

Liposome Drug Delivery Segment by Application

Fungal Infection Therapy

Cancer & Tumor Therapy

Others

Liposome Drug Delivery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposome Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Drug Delivery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Liposome Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Liposomal Doxorubicin Table 2. Major Company of Liposomal Amphoteracin B Table 3. Major Company of Liposomal Paclitaxel Table 4. Major Company of Others Table 5. Global Liposome Drug Delivery Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial) Table 7. Global Liposome Drug Delivery Sales Market Share in Volume by Type (2021-2026) Table 8. Global Liposome Drug Delivery Sales by Type (2021-2026) & (US$ Million) Table 9. Global Liposome Drug Delivery Sales Market Share in Value by Type (2021-2026) Table 10. Global Liposome Drug Delivery Price by Type (2021-2026) & (USD/Vial) Table 11. Global Liposome Drug Delivery Sales by Type (2027-2032) & (K Vial) Table 12. Global Liposome Drug Delivery Sales Market Share in Volume by Type (2027-2032) Table 13. Global Liposome Drug Delivery Sales by Type (2027-2032) & (US$ Million) Table 14. Global Liposome Drug Delivery Sales Market Share in Value by Type (2027-2032) Table 15. Global Liposome Drug Delivery Price by Type (2027-2032) & (USD/Vial) Table 16. North America Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial) Table 17. North America Liposome Drug Delivery Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial) Table 19. Europe Liposome Drug Delivery Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial) Table 21. Asia-Pacific Liposome Drug Delivery Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial) Table 23. Latin America Liposome Drug Delivery Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Liposome Drug Delivery Sales by Type (2021-2026) & (K Vial) Table 25. Middle East and Africa Liposome Drug Delivery Sales by Type (2021-2026) & (US$ Million) Table 26. Liposome Drug Delivery Industry Trends Table 27. Liposome Drug Delivery Industry Drivers Table 28. Liposome Drug Delivery Industry Opportunities and Challenges Table 29. Liposome Drug Delivery Industry Restraints Table 30. Global Liposome Drug Delivery Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Liposome Drug Delivery Revenue Market Share by Company (2021-2026) Table 32. Global Liposome Drug Delivery Sales by Company (2021-2026) & (K Vial) Table 33. Global Liposome Drug Delivery Sales Share by Company (2021-2026) Table 34. Global Liposome Drug Delivery Market Price by Company (2021-2026) & (USD/Vial) Table 35. Global Liposome Drug Delivery Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Liposome Drug Delivery Major Company Production Sites and Headquarters Table 37. Global Liposome Drug Delivery Company, Product Type & Application Table 38. Global Liposome Drug Delivery Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Liposome Drug Delivery Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Liposome Drug Delivery Sales by Region (2021-2026) & (K Vial) Table 43. Global Liposome Drug Delivery Sales Market Share in Volume by Region (2021-2026) Table 44. Global Liposome Drug Delivery Sales by Region (2021-2026) & (US$ Million) Table 45. Global Liposome Drug Delivery Sales Market Share in Value by Region (2021-2026) Table 46. Global Liposome Drug Delivery Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 47. Global Liposome Drug Delivery Sales by Region (2027-2032) & (K Vial) Table 48. Global Liposome Drug Delivery Sales Market Share in Volume by Region (2027-2032) Table 49. Global Liposome Drug Delivery Sales by Region (2027-2032) & (US$ Million) Table 50. Global Liposome Drug Delivery Sales Market Share in Value by Region (2027-2032) Table 51. Global Liposome Drug Delivery Sales (K Vial), Value (US$ Million), Price (USD/Vial) and Gross Margin (2027-2032) Table 52. Global Liposome Drug Delivery Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial) Table 54. Global Liposome Drug Delivery Sales Market Share in Volume by Application (2021-2026) Table 55. Global Liposome Drug Delivery Sales by Application (2021-2026) & (US$ Million) Table 56. Global Liposome Drug Delivery Sales Market Share in Value by Application (2021-2026) Table 57. Global Liposome Drug Delivery Price by Application (2021-2026) & (USD/Vial) Table 58. Global Liposome Drug Delivery Sales by Application (2027-2032) & (K Vial) Table 59. Global Liposome Drug Delivery Sales Market Share in Volume by Application (2027-2032) Table 60. Global Liposome Drug Delivery Sales by Application (2027-2032) & (US$ Million) Table 61. Global Liposome Drug Delivery Sales Market Share in Value by Application (2027-2032) Table 62. Global Liposome Drug Delivery Price by Application (2027-2032) & (USD/Vial) Table 63. North America Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial) Table 64. North America Liposome Drug Delivery Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial) Table 66. Europe Liposome Drug Delivery Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial) Table 68. Asia-Pacific Liposome Drug Delivery Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial) Table 70. Latin America Liposome Drug Delivery Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Liposome Drug Delivery Sales by Application (2021-2026) & (K Vial) Table 72. Middle East and Africa Liposome Drug Delivery Sales by Application (2021-2026) & (US$ Million) Table 73. Gilead Sciences Company Information Table 74. Gilead Sciences Business Overview Table 75. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 76. Gilead Sciences Liposome Drug Delivery Product Portfolio Table 77. Gilead Sciences Recent Development Table 78. Pacira Company Information Table 79. Pacira Business Overview Table 80. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 81. Pacira Liposome Drug Delivery Product Portfolio Table 82. Pacira Recent Development Table 83. Sun Pharmaceutical Company Information Table 84. Sun Pharmaceutical Business Overview Table 85. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 86. Sun Pharmaceutical Liposome Drug Delivery Product Portfolio Table 87. Sun Pharmaceutical Recent Development Table 88. Johnson & Johnson Company Information Table 89. Johnson & Johnson Business Overview Table 90. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 91. Johnson & Johnson Liposome Drug Delivery Product Portfolio Table 92. Johnson & Johnson Recent Development Table 93. Luye Pharma Company Information Table 94. Luye Pharma Business Overview Table 95. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 96. Luye Pharma Liposome Drug Delivery Product Portfolio Table 97. Luye Pharma Recent Development Table 98. Sigma-Tau Company Information Table 99. Sigma-Tau Business Overview Table 100. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 101. Sigma-Tau Liposome Drug Delivery Product Portfolio Table 102. Sigma-Tau Recent Development Table 103. Ipsen (Onivyde) Company Information Table 104. Ipsen (Onivyde) Business Overview Table 105. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 106. Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio Table 107. Ipsen (Onivyde) Recent Development Table 108. CSPC Company Information Table 109. CSPC Business Overview Table 110. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 111. CSPC Liposome Drug Delivery Product Portfolio Table 112. CSPC Recent Development Table 113. Teva Pharmaceutical Company Information Table 114. Teva Pharmaceutical Business Overview Table 115. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 116. Teva Pharmaceutical Liposome Drug Delivery Product Portfolio Table 117. Teva Pharmaceutical Recent Development Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 121. Novartis Liposome Drug Delivery Product Portfolio Table 122. Novartis Recent Development Table 123. Fudan-Zhangjiang Company Information Table 124. Fudan-Zhangjiang Business Overview Table 125. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026) Table 126. Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio Table 127. Fudan-Zhangjiang Recent Development Table 128. North America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2021 VS 2025 VS 2032 Table 129. North America Liposome Drug Delivery Sales by Country (2021-2026) & (K Vial) Table 130. North America Liposome Drug Delivery Sales Market Share by Country (2021-2026) Table 131. North America Liposome Drug Delivery Sales Forecast by Country (2027-2032) & (K Vial) Table 132. North America Liposome Drug Delivery Sales Market Share Forecast by Country (2027-2032) Table 133. North America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Liposome Drug Delivery Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Liposome Drug Delivery Market Share by Country (2021-2026) Table 136. North America Liposome Drug Delivery Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Liposome Drug Delivery Market Share Forecast by Country (2027-2032) Table 138. Europe Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2021 VS 2025 VS 2032 Table 139. Europe Liposome Drug Delivery Sales by Country (2021-2026) & (K Vial) Table 140. Europe Liposome Drug Delivery Sales Market Share by Country (2021-2026) Table 141. Europe Liposome Drug Delivery Sales Forecast by Country (2027-2032) & (K Vial) Table 142. Europe Liposome Drug Delivery Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Liposome Drug Delivery Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Liposome Drug Delivery Market Share by Country (2021-2026) Table 146. Europe Liposome Drug Delivery Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Liposome Drug Delivery Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Liposome Drug Delivery Sales by Country (2021-2026) & (K Vial) Table 150. Asia-Pacific Liposome Drug Delivery Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Liposome Drug Delivery Sales Forecast by Country (2027-2032) & (K Vial) Table 152. Asia-Pacific Liposome Drug Delivery Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Liposome Drug Delivery Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Liposome Drug Delivery Market Share by Country (2021-2026) Table 156. Asia-Pacific Liposome Drug Delivery Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Liposome Drug Delivery Market Share Forecast by Country (2027-2032) Table 158. Latin America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2021 VS 2025 VS 2032 Table 159. Latin America Liposome Drug Delivery Sales by Country (2021-2026) & (K Vial) Table 160. Latin America Liposome Drug Delivery Sales Market Share by Country (2021-2026) Table 161. Latin America Liposome Drug Delivery Sales Forecast by Country (2027-2032) & (K Vial) Table 162. Latin America Liposome Drug Delivery Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Liposome Drug Delivery Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Liposome Drug Delivery Market Share by Country (2021-2026) Table 166. Latin America Liposome Drug Delivery Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Liposome Drug Delivery Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (K Vial): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Liposome Drug Delivery Sales by Country (2021-2026) & (K Vial) Table 170. Middle East and Africa Liposome Drug Delivery Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Liposome Drug Delivery Sales Forecast by Country (2027-2032) & (K Vial) Table 172. Middle East and Africa Liposome Drug Delivery Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Liposome Drug Delivery Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Liposome Drug Delivery Market Share by Country (2021-2026) Table 176. Middle East and Africa Liposome Drug Delivery Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Liposome Drug Delivery Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Liposome Drug Delivery Distributors List Table 181. Liposome Drug Delivery Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Liposome Drug Delivery Image Figure 2. Global Liposome Drug Delivery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposome Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 4. Global Liposome Drug Delivery Sales (2021-2032) & (K Vial) Figure 5. Liposomal Doxorubicin Image Figure 6. Global Liposomal Doxorubicin Sales YoY Growth (2021-2032) & (K Vial) Figure 7. Liposomal Amphoteracin B Image Figure 8. Global Liposomal Amphoteracin B Sales YoY Growth (2021-2032) & (K Vial) Figure 9. Liposomal Paclitaxel Image Figure 10. Global Liposomal Paclitaxel Sales YoY Growth (2021-2032) & (K Vial) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Vial) Figure 13. Global Liposome Drug Delivery Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Liposome Drug Delivery Market Share by Type 2025 VS 2032 Figure 15. North America Liposome Drug Delivery Sales Market Share in Volume by Type in 2025 Figure 16. North America Liposome Drug Delivery Sales Market Share in Value by Type in 2025 Figure 17. Europe Liposome Drug Delivery Sales Market Share in Volume by Type in 2025 Figure 18. Europe Liposome Drug Delivery Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Liposome Drug Delivery Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Liposome Drug Delivery Sales Market Share in Value by Type in 2025 Figure 21. Latin America Liposome Drug Delivery Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Liposome Drug Delivery Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Liposome Drug Delivery Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Liposome Drug Delivery Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Fungal Infection Therapy Image Figure 28. Global Fungal Infection Therapy Sales YoY Growth (2021-2032) & (K Vial) Figure 29. Cancer & Tumor Therapy Image Figure 30. Global Cancer & Tumor Therapy Sales YoY Growth (2021-2032) & (K Vial) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Vial) Figure 33. Global Liposome Drug Delivery Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Liposome Drug Delivery Market Share by Application 2025 VS 2032 Figure 35. North America Liposome Drug Delivery Sales Market Share in Volume by Application in 2025 Figure 36. North America Liposome Drug Delivery Sales Market Share in Value by Application in 2025 Figure 37. Europe Liposome Drug Delivery Sales Market Share in Volume by Application in 2025 Figure 38. Europe Liposome Drug Delivery Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Liposome Drug Delivery Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Liposome Drug Delivery Sales Market Share in Value by Application in 2025 Figure 41. Latin America Liposome Drug Delivery Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Liposome Drug Delivery Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Liposome Drug Delivery Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Liposome Drug Delivery Sales Market Share in Value by Application in 2025 Figure 45. North America Liposome Drug Delivery Sales by Country: 2021 VS 2025 VS 2032 (K Vial) Figure 46. North America Liposome Drug Delivery Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Liposome Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Liposome Drug Delivery Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Liposome Drug Delivery Sales by Country: 2021 VS 2025 VS 2032 (K Vial) Figure 50. Europe Liposome Drug Delivery Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Liposome Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Liposome Drug Delivery Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Liposome Drug Delivery Sales by Country: 2021 VS 2025 VS 2032 (K Vial) Figure 54. Asia-Pacific Liposome Drug Delivery Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Liposome Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Liposome Drug Delivery Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Liposome Drug Delivery Sales by Country: 2021 VS 2025 VS 2032 (K Vial) Figure 58. Latin America Liposome Drug Delivery Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Liposome Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Liposome Drug Delivery Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Liposome Drug Delivery Sales by Country: 2021 VS 2025 VS 2032 (K Vial) Figure 62. Middle East and Africa Liposome Drug Delivery Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Liposome Drug Delivery Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Liposome Drug Delivery Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Liposome Drug Delivery Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Liposome Drug Delivery Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others
Applications
  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Others
Companies covered
  • Gilead Sciences
  • Pacira
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Luye Pharma
  • Sigma-Tau
  • Ipsen (Onivyde)
  • CSPC
  • Teva Pharmaceutical
  • Novartis
  • Fudan-Zhangjiang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Liposome Drug Delivery Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Liposome Drug Delivery Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Liposome Drug Delivery Market by Type
  6. 1.3.1 Liposomal Doxorubicin
  7. 1.3.2 Liposomal Amphoteracin B
  8. 1.3.3 Liposomal Paclitaxel
  9. 1.3.4 Others
  10. 1.4 Global Liposome Drug Delivery Market Size by Type
  11. 1.4.1 Global Liposome Drug Delivery Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Liposome Drug Delivery Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Liposome Drug Delivery Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Liposome Drug Delivery Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Liposome Drug Delivery Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Liposome Drug Delivery Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Liposome Drug Delivery Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Liposome Drug Delivery Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Liposome Drug Delivery Industry Trends
  2. 2.2 Liposome Drug Delivery Industry Drivers
  3. 2.3 Liposome Drug Delivery Industry Opportunities and Challenges
  4. 2.4 Liposome Drug Delivery Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Liposome Drug Delivery Revenue (2021-2026)
  2. 3.2 Global Top Players by Liposome Drug Delivery Sales (2021-2026)
  3. 3.3 Global Top Players by Liposome Drug Delivery Price (2021-2026)
  4. 3.4 Global Liposome Drug Delivery Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Liposome Drug Delivery Major Company Production Sites & Headquarters
  6. 3.6 Global Liposome Drug Delivery Company, Product Type & Application
  7. 3.7 Global Liposome Drug Delivery Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Liposome Drug Delivery Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Liposome Drug Delivery Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Liposome Drug Delivery Tier 1, Tier 2, and Tier 3
4 Liposome Drug Delivery Regional Status and Outlook
  1. 4.1 Global Liposome Drug Delivery Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Liposome Drug Delivery Historic Market Size by Region
  3. 4.2.1 Global Liposome Drug Delivery Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Liposome Drug Delivery Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Liposome Drug Delivery Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Liposome Drug Delivery Forecasted Market Size by Region
  7. 4.3.1 Global Liposome Drug Delivery Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Liposome Drug Delivery Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Liposome Drug Delivery Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Liposome Drug Delivery by Application
  1. 5.1 Liposome Drug Delivery Market by Application
  2. 5.1.1 Fungal Infection Therapy
  3. 5.1.2 Cancer & Tumor Therapy
  4. 5.1.3 Others
  5. 5.2 Global Liposome Drug Delivery Market Size by Application
  6. 5.2.1 Global Liposome Drug Delivery Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Liposome Drug Delivery Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Liposome Drug Delivery Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Liposome Drug Delivery Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Liposome Drug Delivery Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Liposome Drug Delivery Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Liposome Drug Delivery Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Liposome Drug Delivery Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Gilead Sciences
  2. 6.1.1 Gilead Sciences Company Information
  3. 6.1.2 Gilead Sciences Business Overview
  4. 6.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Gilead Sciences Liposome Drug Delivery Product Portfolio
  6. 6.1.5 Gilead Sciences Recent Developments
  7. 6.2 Pacira
  8. 6.2.1 Pacira Company Information
  9. 6.2.2 Pacira Business Overview
  10. 6.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pacira Liposome Drug Delivery Product Portfolio
  12. 6.2.5 Pacira Recent Developments
  13. 6.3 Sun Pharmaceutical
  14. 6.3.1 Sun Pharmaceutical Company Information
  15. 6.3.2 Sun Pharmaceutical Business Overview
  16. 6.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharmaceutical Liposome Drug Delivery Product Portfolio
  18. 6.3.5 Sun Pharmaceutical Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Liposome Drug Delivery Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Luye Pharma
  26. 6.5.1 Luye Pharma Company Information
  27. 6.5.2 Luye Pharma Business Overview
  28. 6.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Luye Pharma Liposome Drug Delivery Product Portfolio
  30. 6.5.5 Luye Pharma Recent Developments
  31. 6.6 Sigma-Tau
  32. 6.6.1 Sigma-Tau Company Information
  33. 6.6.2 Sigma-Tau Business Overview
  34. 6.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sigma-Tau Liposome Drug Delivery Product Portfolio
  36. 6.6.5 Sigma-Tau Recent Developments
  37. 6.7 Ipsen (Onivyde)
  38. 6.7.1 Ipsen (Onivyde) Company Information
  39. 6.7.2 Ipsen (Onivyde) Business Overview
  40. 6.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ipsen (Onivyde) Liposome Drug Delivery Product Portfolio
  42. 6.7.5 Ipsen (Onivyde) Recent Developments
  43. 6.8 CSPC
  44. 6.8.1 CSPC Company Information
  45. 6.8.2 CSPC Business Overview
  46. 6.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CSPC Liposome Drug Delivery Product Portfolio
  48. 6.8.5 CSPC Recent Developments
  49. 6.9 Teva Pharmaceutical
  50. 6.9.1 Teva Pharmaceutical Company Information
  51. 6.9.2 Teva Pharmaceutical Business Overview
  52. 6.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Pharmaceutical Liposome Drug Delivery Product Portfolio
  54. 6.9.5 Teva Pharmaceutical Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Liposome Drug Delivery Product Portfolio
  60. 6.10.5 Novartis Recent Developments
  61. 6.11 Fudan-Zhangjiang
  62. 6.11.1 Fudan-Zhangjiang Company Information
  63. 6.11.2 Fudan-Zhangjiang Business Overview
  64. 6.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Fudan-Zhangjiang Liposome Drug Delivery Product Portfolio
  66. 6.11.5 Fudan-Zhangjiang Recent Developments
7 North America by Country
  1. 7.1 North America Liposome Drug Delivery Sales by Country
  2. 7.1.1 North America Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Liposome Drug Delivery Sales by Country (2021-2026)
  4. 7.1.3 North America Liposome Drug Delivery Sales Forecast by Country (2027-2032)
  5. 7.2 North America Liposome Drug Delivery Market Size by Country
  6. 7.2.1 North America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Liposome Drug Delivery Market Size by Country (2021-2026)
  8. 7.2.3 North America Liposome Drug Delivery Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Liposome Drug Delivery Sales by Country
  2. 8.1.1 Europe Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Liposome Drug Delivery Sales by Country (2021-2026)
  4. 8.1.3 Europe Liposome Drug Delivery Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Liposome Drug Delivery Market Size by Country
  6. 8.2.1 Europe Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Liposome Drug Delivery Market Size by Country (2021-2026)
  8. 8.2.3 Europe Liposome Drug Delivery Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Liposome Drug Delivery Sales by Country
  2. 9.1.1 Asia-Pacific Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Liposome Drug Delivery Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Liposome Drug Delivery Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Liposome Drug Delivery Market Size by Country
  6. 9.2.1 Asia-Pacific Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Liposome Drug Delivery Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Liposome Drug Delivery Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Liposome Drug Delivery Sales by Country
  2. 10.1.1 South America Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Liposome Drug Delivery Sales by Country (2021-2026)
  4. 10.1.3 South America Liposome Drug Delivery Sales Forecast by Country (2027-2032)
  5. 10.2 South America Liposome Drug Delivery Market Size by Country
  6. 10.2.1 South America Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Liposome Drug Delivery Market Size by Country (2021-2026)
  8. 10.2.3 South America Liposome Drug Delivery Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Liposome Drug Delivery Sales by Country
  2. 11.1.1 Middle East and Africa Liposome Drug Delivery Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Liposome Drug Delivery Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Liposome Drug Delivery Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Liposome Drug Delivery Market Size by Country
  6. 11.2.1 Middle East and Africa Liposome Drug Delivery Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Liposome Drug Delivery Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Liposome Drug Delivery Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Liposome Drug Delivery Value Chain Analysis
  2. 12.1.1 Liposome Drug Delivery Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Liposome Drug Delivery Production Mode & Process
  7. 12.2 Liposome Drug Delivery Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Liposome Drug Delivery Distributors
  10. 12.2.3 Liposome Drug Delivery Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst